Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Viking Thera (VKTX)

Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,121,455
  • Shares Outstanding, K 111,436
  • Annual Sales, $ 0 K
  • Annual Income, $ -85,900 K
  • EBIT $ -134 M
  • EBITDA $ -142 M
  • 60-Month Beta 1.00
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 8.77

Options Overview Details

View History
  • Implied Volatility 102.70% ( -6.78%)
  • Historical Volatility 77.25%
  • IV Percentile 61%
  • IV Rank 43.71%
  • IV High 234.70% on 02/16/24
  • IV Low 0.20% on 02/27/24
  • Put/Call Vol Ratio 0.36
  • Today's Volume 43,679
  • Volume Avg (30-Day) 28,854
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 235,182
  • Open Int (30-Day) 205,375

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.28
  • Number of Estimates 10
  • High Estimate -0.24
  • Low Estimate -0.33
  • Prior Year -0.25
  • Growth Rate Est. (year over year) -12.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.01 +21.45%
on 10/23/24
81.73 -10.83%
on 10/28/24
+10.88 (+17.55%)
since 10/01/24
3-Month
47.31 +54.05%
on 08/05/24
81.73 -10.83%
on 10/28/24
+18.23 (+33.36%)
since 08/01/24
52-Week
9.34 +680.30%
on 11/10/23
99.41 -26.69%
on 02/28/24
+63.31 (+661.55%)
since 11/01/23

Most Recent Stories

More News
Viking Therapeutics Stock: A Pre-Election Bet Worth Considering

Viking Therapeutics is making headway in the weight loss drug market; but even though the payoff is years away, there's still plenty of upside for investors

VKTX : 72.88 (+0.47%)
NVO : 111.94 (-0.01%)
LLY : 818.93 (-1.30%)
GS : 519.35 (+0.30%)
This High-Flying Stock Just Became a Better Buy

It might not be too late to get in on the party.

VKTX : 72.88 (+0.47%)
Up 285% YTD, Is It Too Late to Buy This Biotech Stock?

Viking Therapeutics is making notable advancements in obesity treatment with VK2735 and exploring strategic partnerships for its NASH program, positioning itself at the forefront of metabolic and endocrine...

VKTX : 72.88 (+0.47%)
LLY : 818.93 (-1.30%)
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?

Novo Nordisk dominates diabetes treatment and obesity care, but one clinical-stage pharma company could be the next breakout star.

VKTX : 72.88 (+0.47%)
Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday

The company provided clear evidence that it has plenty of resources to continue developing a potential blockbuster drug.

VKTX : 72.88 (+0.47%)
VKTX Beats on Q3 Earnings, Stock Up on Obesity Pipeline Advancements

Viking Therapeutics VKTX reported third-quarter 2024 loss per share of 22 cents, narrower than the Zacks Consensus Estimate of a loss of 24 cents. The company had incurred a loss of 23 cents per share...

FOLD : 11.47 (+0.44%)
VKTX : 72.88 (+0.47%)
CSTL : 33.15 (-4.38%)
FATE : 2.43 (+2.53%)
Health and Wellness Industry Embraces Surge in Demand for Weight Loss Drugs

/CNW/ -- USA News Group News Commentary – With more than 100 million Americans struggling with obesity, and obesity rates increasing on every continent, it's...

VKTX : 72.88 (+0.47%)
NVO : 111.94 (-0.01%)
MS : 116.85 (+0.52%)
LLY : 818.93 (-1.30%)
RHHBY : 39.2600 (+1.16%)
VEGA.CN : 0.3750 (-5.06%)
PLTXF : 0.2765 (-4.62%)
3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)

Regardless of who wins the presidency, investors are better off focusing on top growth stocks.

MSTR : 229.71 (-6.05%)
VKTX : 72.88 (+0.47%)
NVDA : 135.40 (+1.99%)
SMCI : 26.05 (-10.51%)
Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future

Viking recently announced the results of an early-stage clinical trial for VK0214.

VKTX : 72.88 (+0.47%)
Where Will Viking Therapeutics Be in 5 Years?

We could be witnessing the birth of a major player in the biotech industry.

VKTX : 72.88 (+0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Viking Therapeutics, Inc. is a biopharmaceutical company. The company is engaged in development of novel therapies for metabolic and endocrine disorders. Its product candidate consists of VK5211, VK0214, VK0612 and VK2809 which are in different clinical trial. Viking Therapeutics, Inc. is based in LA...

See More

Key Turning Points

3rd Resistance Point 77.45
2nd Resistance Point 76.37
1st Resistance Point 74.62
Last Price 72.88
1st Support Level 71.79
2nd Support Level 70.71
3rd Support Level 68.96

See More

52-Week High 99.41
Last Price 72.88
Fibonacci 61.8% 65.00
Fibonacci 50% 54.38
Fibonacci 38.2% 43.75
52-Week Low 9.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar